首页> 外文期刊>中德临床肿瘤学杂志(英文版) >经动脉灌注健择化疗联合三维适形放射治疗局部晚期胰腺癌的临床研究
【24h】

经动脉灌注健择化疗联合三维适形放射治疗局部晚期胰腺癌的临床研究

机译:经动脉灌注健择化疗联合三维适形放射治疗局部晚期胰腺癌的临床研究

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To evaluate Ihe clinical effect of transarterial infusion chemotherapy of gemcitabine plus three dimensional conformal radiotherapy on patients with local advanced pancreatic cancer.Methods:Fifty-one patients with Jocal advanced pancreatic cancer from June 2002 to February 2004 were enrolled.twenty-four patients of combined group were treared with transarterial infusion chemotherapy of gemcitabine plus three dimensional conformal radiotherapy.while twenty-seven patients of control group were treated only with transarterial infusion chemotherapy of gemcitabine.Results:There were significant statistical differences between two groupsin clinical benefil response(91.7%versus 74.1%,P<0.01)and overall remission rate(70.8%versus 33.3%,P<0.01).The 6-month survival rate,12-month survival rate and 24-month survival rate of combined group were 83.3%,62.5%and 37.5%respectively,while that of control group were 55.6%,33.3%and 11.1% respectively.This showed significant difierence between the two qroups.Conclusion:Transarterial infusion chemotherapy of gemcitabine plus three dimensional conformal radiotherapy may be better than single transarterial infusion chemotherapy of gemcitabine in improving survival rates and elongating survival time of patients with local advanced pancreatic cancer.
机译:目的:评价吉西他滨龙霉素输液化疗对局部晚期胰腺癌患者的临床疗效。2002年6月至2004年2月从2002年6月至2004年2月患有50名牛仔晚期胰腺癌患者的临床疗效。结合组患有牙动脉灌注化化疗的牙甲三三次霉素加上三维保形放疗。几十七名对照组患者仅伴有牙甲胺的常规输注化疗治疗。结果:两种临床受益者反应之间存在显着的统计差异(91.7 %与74.1%,p <0.01)和总缓解率(70.8%对33.3%,p <0.01)。6个月的存活率,12个月的存活率和合并组的24个月存活率为83.3%,分别为62.5%和37.5%,而对照组分别分别为55.6%,33.3%和11.1%。这在th之间显示出显着的差异E两种Qroups.Concitabine的Cryarterial Infusion Chemotherapy Plus三维保形放疗可以优于吉西他滨的单晶静脉输液化疗,从而提高局部晚期胰腺癌患者的存活率和伸长生存时间。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号